CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics Inc 's Leverage Ratio

ATRA's quarterly Leverage Ratio and Total Liabilities, Equity growth




ATRA Leverage Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity Change -10.96 % -14.19 % -20.99 % -48.67 % -35.35 %
Y / Y Total Liabilities Change 14.54 % 54.45 % 28.43 % 24.8 % 47.86 %
Leverage Ratio MRQ 0.18 0.18 0.15 0.18 0.14
Overall Ranking # # # # #
Seq. Equity Change -13.05 % -8.69 % 37.09 % -18.19 % -16.21 %
Seq. Total Liabilities Change -10.42 % 12.55 % 10.7 % 2.63 % 20.79 %



Leverage Ratio first quarter 2020 Comment
Due to repayements of liabilities of -10.42% Atara Biotherapeutics Inc improved Leverage Ratio in first quarter 2020 to 0.18, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2020, 43 other companies have achieved lower Leverage Ratio than Atara Biotherapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are ATRA Customers?
Leverage Ratio first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 44
Healthcare Sector # 162
Overall Market # 370


Leverage Ratio Statistics
High Average Low
0.2 0.08 0.02
(Dec 31 2017)  




Financial Statements
Atara Biotherapeutics Inc 's Equity $ 253 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics Inc 's Total Liabilities $ 47 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2020, within Biotechnology & Drugs Industry Leverage RatioMar 31 2020 MRQ Total LiabilitiesMar 31 2020 MRQ Equity
Pluristem Therapeutics Inc  0.50 $ 7.068  Millions$ 14.169  Millions
Unity Biotechnology Inc   0.50 $ 52.458  Millions$ 105.329  Millions
Myriad Genetics Inc   0.50 $ 479.500  Millions$ 967.200  Millions
Capricor Therapeutics Inc   0.49 $ 4.673  Millions$ 9.593  Millions
Sangamo Therapeutics Inc   0.48 $ 189.985  Millions$ 394.415  Millions
Fate Therapeutics Inc  0.47 $ 102.672  Millions$ 219.218  Millions
Pulse Biosciences Inc   0.46 $ 10.073  Millions$ 21.768  Millions
Precipio Inc   0.46 $ 5.170  Millions$ 11.285  Millions
Scpharmaceuticals Inc   0.44 $ 24.131  Millions$ 55.104  Millions
Orgenesis Inc   0.42 $ 37.695  Millions$ 89.663  Millions
Gritstone Oncology Inc   0.41 $ 47.629  Millions$ 115.389  Millions
Delmar Pharmaceuticals Inc   0.37 $ 1.382  Millions$ 3.720  Millions
Bluebird Bio Inc   0.36 $ 408.671  Millions$ 1,120.433  Millions
Vericel Corporation  0.36 $ 39.813  Millions$ 110.452  Millions
Proteostasis Therapeutics Inc   0.35 $ 18.770  Millions$ 53.140  Millions
Strongbridge Biopharma Plc  0.35 $ 21.368  Millions$ 61.179  Millions
Celldex Therapeutics Inc   0.34 $ 28.801  Millions$ 83.703  Millions
Cue Biopharma Inc   0.34 $ 15.413  Millions$ 45.236  Millions
Akers Biosciences Inc   0.34 $ 2.304  Millions$ 6.817  Millions
Momenta Pharmaceuticals inc   0.33 $ 140.553  Millions$ 428.193  Millions
Armata Pharmaceuticals Inc   0.32 $ 10.620  Millions$ 33.482  Millions
Solid Biosciences Inc   0.31 $ 17.504  Millions$ 56.456  Millions
Frequency Therapeutics Inc   0.31 $ 50.872  Millions$ 164.849  Millions
Heska Corp  0.30 $ 80.343  Millions$ 270.638  Millions
Atyr Pharma Inc  0.29 $ 12.319  Millions$ 41.967  Millions
Caladrius Biosciences Inc   0.29 $ 4.897  Millions$ 16.984  Millions
Repligen Corp  0.29 $ 305.938  Millions$ 1,069.758  Millions
Spero Therapeutics Inc   0.28 $ 22.946  Millions$ 82.427  Millions
Denali Therapeutics Inc   0.28 $ 150.554  Millions$ 545.311  Millions
Homology Medicines Inc   0.27 $ 62.247  Millions$ 226.541  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WHLR's Profile

Stock Price

WHLR's Financials

Business Description

Fundamentals

Charts & Quotes

WHLR's News

Suppliers

WHLR's Competitors

Customers & Markets

Economic Indicators

WHLR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071